Company Overview

Corium is a biopharmaceutical company that develops and commercializes novel neuroscience therapies using its transdermal delivery technology.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Corium Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Corium Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Private Equity	10/20/2022
Debt	9/27/2021
M&A	11/27/2018
Debt	12/4/2014
IPO	4/3/2014
Debt	7/13/2012

View all Funding Rounds

Corium Investors

Notable investors and investment history

Investor	Rounds
Hercules Capital	Debt
Aphelion Capital	Series B, Series C
Quantum Technology Partners	Series B, Series A, Series C
EW Healthcare Partners	Series A, Series C
Needham & Company	IPO
CRG	Debt
Gurnet Point Capital	Private Equity, M&A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Oct 20, 2022
$100M round led by Webster Equity Partners.
Sep 27, 2021
$235M raised, led by Hercules Capital.

View all signals

Corium Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Corium Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Corium's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts

Year Founded1999

Last Funding10/20/2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

Login

Use CasesInvestors Employees

CompaniesAll Companies

LegalPrivacy Policy Terms of Use BrokerCheck Form CRS

DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.